This brand name is authorized in Austria, Australia, Canada, Cyprus, Germany, Ecuador, Spain, Hong Kong, Italy, Japan, Malta, Mexico, Nigeria, Singapore, United Kingdom, United States, South Africa
The drug TENORMIN contains one active pharmaceutical ingredient (API):
|
1
Atenolol
UNII 50VV3VW0TI - ATENOLOL
|
|
Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| TENORMIN Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| TENORMIN Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C07AB03 | Atenolol | C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 1081X |
| Country: CA | Health Products and Food Branch | Identifier(s): 02039532, 02039540 |
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 02477686 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 361630812, 362951112 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 56777, 56967 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 13308, 27862 |
| Country: HK | Department of Health Drug Office | Identifier(s): 06812, 17873 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 024016038 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2123011F1155, 2123011F2437 |
| Country: MT | Medicines Authority | Identifier(s): AA565/41701 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 88870 |
| Country: NG | Registered Drug Product Database | Identifier(s): 04-0336 |
| Country: SG | Health Sciences Authority | Identifier(s): 00348P, 08669P |
| Country: US | FDA, National Drug Code | Identifier(s): 52427-429, 52427-430, 52427-431 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 27/5.2/0251, J/5.2/0120, P/5.2/174, P/5.2/268 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
